Biodistribution studies for cell therapy products: Current status and issues

Biodistribution studies for cell therapy products: Current status and issues

Information on the biodistribution (BD) of cell therapy products (CTPs) is essential for prediction and assessment of their efficacy and toxicity profiles in non-clinical and clinical studies. To conduct BD studies, it is necessary to understand regulatory requirements, implementation status, and an...

Full description

Bibliographic Details
Main Authors: Yoshiteru Kamiyama, Yoichi Naritomi, Yuu Moriya, Syunsuke Yamamoto, Tsukasa Kitahashi, Toshihiko Maekawa, Masahiro Yahata, Takeshi Hanada, Asako Uchiyama, Akari Noumaru, Yoshiyuki Koga, Tomoaki Higuchi, Masahiko Ito, Hiroyuki Komatsu, Sosuke Miyoshi, Sadaaki Kimura, Nobuhiro Umeda, Eriko Fujita, Naoko Tanaka, Taku Sugita, Satoru Takayama, Akihiko Kurogi, Satoshi Yasuda, Yoji Sato
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Regenerative Therapy
Subjects:
Biodistribution
Cell therapy product
qPCR
Imaging
PET
SPECT
Online Access:http://www.sciencedirect.com/science/article/pii/S235232042100050X

Internet

http://www.sciencedirect.com/science/article/pii/S235232042100050X

Similar Items